SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-18-008860
Filing Date
2018-02-14
Accepted
2018-02-14 16:03:37
Documents
1
Group Members
FRED KNOLLGAKASA HOLDINGS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tv485766_sc13ga.htm SC 13G/A 76635
  Complete submission text file 0001144204-18-008860.txt   78289
Mailing Address 5 EAST 44TH STREET 12TH FLOOR NEW YORK NY 10017
Business Address 5 EAST 44TH STREET 12TH FLOOR NEW YORK NY 10017 212-808-7474
Knoll Capital Management, LP (Filed by) CIK: 0001325083 (see all company filings)

IRS No.: 133476926 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Subject) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88716 | Film No.: 18612161
SIC: 2834 Pharmaceutical Preparations